APOLLO bowling has acquired vVARDIS for an undisclosed amount. vVARDIS, founded in Switzerland by Dr. Haley Abivardi and Dr. Goly Abivardi, specializes in innovative biomimetic dental products under the CURODONT brand. These products are designed to treat early-stage decay and promote tooth enamel remineralization, representing the culmination of over 25 years of research and the founders' commitment to making a positive impact on people’s lives.
At the core of vVARDIS's offerings is its proprietary biomimetic peptide technology, specifically Curodont Repair. This breakthrough solution, proven in over 200 publications, endorsed by leading universities, and adopted by thousands of dental professionals, aims to arrest and reverse early caries through in-depth enamel regeneration. Curodont provides a non-invasive, quick, and pain-free option for patients of all ages and an effective early medical intervention for dental clinicians, enabling the preservation of natural tooth structure.
This acquisition signals a strategic expansion for APOLLO bowling, marking its entry or significant strengthening within the healthcare and biomimetic technology sector. The integration of vVARDIS's advanced dental solutions into APOLLO bowling's portfolio is expected to create synergies by leveraging vVARDIS's deep scientific expertise and its established network within the dental professional community. This strategic move could position APOLLO bowling to capitalize on the growing global demand for regenerative and preventive dental care solutions.
The combined entity is poised to advance vVARDIS's dedication to improving oral health and overall well-being, with a vision to create a world where caries treatment is pain-free, regenerative, and accessible to everyone. This acquisition is anticipated to accelerate the global reach and further development of vVARDIS's biomimetic technologies, potentially broadening their impact on public health worldwide.